Immune System Disorder
27
7
7
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
1 terminated out of 27 trials
91.7%
+5.2% vs benchmark
0%
0 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (27)
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Montreal Immune-Related Adverse Events (MIRAE) Study
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects
Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
Hemogram Parameter Changes With Sepsis Filter
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)
Study on the Effects of Wheat and Corn Germ Blend Oil on Antioxidation and Immune Regulation of Dyslipidemia Population
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer
Preterm Immune System Development and Response to Immunization
Cross-condition Validation of the Steroid PRO
Aerobic Training and Diet Protocol on Immune System in Burn Patients.
COVID-19 Post-Vaccination Observation
Pediatrics HOT COVID-19 Database in NY Tristate
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acids
Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort